About ProDigest
ProDigest is a Healthcare company based in Gentbrugge (Belgium) founded in 2008. Preclinical services for metabolic disease drug development are provided. The company has 45 employees. Its chief executive, as recorded, is Massimo Marzorati. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Metabolic Disease.
Company details
ProDigest was established in 2008 in Gentbrugge, Belgium, as a contract research organization (CRO) in the biotechnology sector. Preclinical services are delivered by the company to support drug development for metabolic diseases. Operations focus on advanced models and testing protocols tailored to gastrointestinal and metabolic research needs. Leadership is provided by CEO Massimo Marzorati, with activities centered in Europe to assist pharmaceutical clients in early-stage development.
- Headquarters Gentbrugge, Belgium
- Employees 45
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website prodigest.eu
- Social LinkedIn X
- Legal Name Prodigest
- Net Profit$11.2 K (USD)-100as on Dec 31, 2022
- EBITDA$379.31 K (USD)-88as on Dec 31, 2022
- Latest Funding Round$293.76K (USD), Grant
Jan 2019
- Investors
- Employee Count45
Funding Insights of ProDigest
- Total Rounds 2
- Last Round Grant — $293,763
- First Round $487,711
(Jan 2017)
- Investors Count 1
All 2 funding rounds of ProDigest with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $293,763 | Grant | – | – | |
| Jan 2017 | $487,711 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in ProDigest
ProDigest has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ProDigest
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ProDigest
1 people are tracked at ProDigest (1 in leadership); the tracked headcount is 45.
| Name | Role | Group |
|---|---|---|
Massimo Marzorati | CEO | Leadership |
Complete people profiles for ProDigest
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ProDigest
3 dated milestones of ProDigest across 11 years, from founding to its latest funding, stage changes and deals.
- Founded ProDigest is founded.
- Funding First funding round of $488K.
- Funding Latest funding round, Grant, of $294K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProDigest
ProDigest was founded in 2008 and raised its 1st funding round 9 years after it was founded.
ProDigest is headquartered in Gentbrugge, Belgium. It is registered at Gentbrugge, East Flanders, Belgium.
Massimo Marzorati is the CEO of ProDigest, as recorded in our data.
ProDigest has 45 employees.
ProDigest was established in 2008 in Gentbrugge, Belgium, as a contract research organization (CRO) in the biotechnology sector. Preclinical services are delivered by the company to support drug development for metabolic diseases. Operations focus on advanced models and testing protocols tailored to gastrointestinal and metabolic research needs. Leadership is provided by CEO Massimo Marzorati, with activities centered in Europe to assist pharmaceutical clients in early-stage development.
ProDigest has 1 investor. Key investors include European Union.
ProDigest operates through Prodigest.